Oxford BioMedica PLC (OTCPK:OXBDF)
$ 4.1 -0.21 (-4.87%) Market Cap: 390.96 Mil Enterprise Value: 400.84 Mil PE Ratio: 0 PB Ratio: 4.01 GF Score: 74/100

Full Year 2022 Oxford Biomedica PLC Earnings Call Transcript

Apr 25, 2023 / 12:00PM GMT
Release Date Price: $5.53
Frank Mathias
Oxford Biomedica plc - CEO & Director

So hello, everyone, and thank you for joining our meeting today, our analyst report meeting -- on the results of 2022. I'm Frank Mathias. I'm the newly appointed Chief Executive Officer of the company. And believe me, it's a great pleasure to meet you today together with our Chief Financial Officer, Stuart Paynter. I believe you are known here.

So just for those who do not know me by now, I'm French, as you can hear from my accent, I'm sure about that. I was born in Paris, and I went to school there and to the university. So I'm pharmacist by education with a PhD in immunology and more than 30 years now of experience in the biopharmaceutical environment in senior positions at different companies throughout the biopharmaceutical industry. As you might know, I come from another renowned CDMO, namely Rentschler Biopharma, where I was CEO for about 7 years.

So also, I have only started 3 weeks ago. To be very precise, 3 weeks, 1.5 days ago. I can already say the following, and this is in line with what I have expected from the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot